Sari Feld Selected Research

Urofacial syndrome

1/2020

Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sari Feld Research Topics

Disease

12	Neoplasms (Cancer) 01/2019 - 06/2008
8	Neoplasm Metastasis (Metastasis) 10/2018 - 03/2009
4	Inflammation (Inflammations) 10/2018 - 03/2009
3	Lymphoma (Lymphomas) 01/2019 - 01/2016
3	Carcinoma (Carcinomatosis) 01/2017 - 01/2016
1	Urofacial syndrome 01/2020
1	Carcinogenesis 01/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2018
1	Pleural Effusion (Pleural Effusions) 10/2018
1	Mesothelioma 10/2018
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2018
1	Breast Neoplasms (Breast Cancer) 10/2018
1	Malignant Mesothelioma 10/2018
1	Lung Neoplasms (Lung Cancer) 04/2018
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Polyps 01/2017
1	Melanoma (Melanoma, Malignant) 11/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2016
1	Sarcoma (Soft Tissue Sarcoma) 01/2016
1	Hematologic Neoplasms (Hematological Malignancy) 01/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2012
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2010
1	Virus Diseases (Viral Diseases) 12/2007
1	Infections 02/2005

Drug/Important Bio-Agent (IBA)

12	heparanaseIBA 01/2019 - 06/2008
8	Heparitin Sulfate (Heparan Sulfate)IBA 01/2019 - 03/2009
4	Glycoside Hydrolases (Endoglycosidases)IBA 10/2018 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2019 - 04/2018
2	GlucuronidaseIBA 01/2019 - 03/2009
2	Biological ProductsIBA 10/2018 - 04/2018
2	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 04/2016 - 01/2016
2	CollagenIBA 04/2016 - 01/2016
2	Monoclonal AntibodiesIBA 01/2016 - 01/2012
2	Proteoglycans (Proteoglycan)IBA 01/2016 - 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	ImmunosorbentsIBA 10/2018
1	EnzymesIBA 10/2018
1	defibrotideIBA 10/2018
1	Cisplatin (Platino)FDA LinkGeneric 04/2018
1	ParaffinIBA 11/2016
1	LuciferasesIBA 01/2016
1	Neutralizing AntibodiesIBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	Vascular Endothelial Growth Factor CIBA 01/2016
1	Heparin (Liquaemin)FDA LinkGeneric 01/2016
1	Antiviral Agents (Antivirals)IBA 12/2007
1	CC ChemokinesIBA 02/2005
1	ChemokinesIBA 02/2005
1	Chemokine CCL5IBA 02/2005
1	LigandsIBA 02/2005
1	Chemokine ReceptorsIBA 02/2005
1	Chemokine CCL4IBA 02/2005
1	Chemokine CCL19IBA 02/2005

Therapy/Procedure

4	Therapeutics 01/2019 - 11/2016
1	Drug Therapy (Chemotherapy) 04/2018